This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Ascorbyl glucoside
- DrugBank Accession Number
- DB11335
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Ascorbyl glucoside (DB11335)
- Weight
- Average: 338.265
Monoisotopic: 338.0849114 - Chemical Formula
- C12H18O11
- Synonyms
- AA-2G
- AA2G
- Ascorbic acid 2-O-glucoside
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Sandawha Vitamin C Brightening Essence Liquid 2 g/100mL Topical SKINCURE INC 2020-11-23 Not applicable US 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image AnubisMed Ascorbyl glucoside (0.25 g/50mL) + Ammonia (2.75 g/50mL) + Ethanol (6.3 mL/50mL) + Ethylhexylglycerin (0.025 g/50mL) + Glycolic acid (17 g/50mL) + Hexylresorcinol (1 g/50mL) + Hydroxyethyl cellulose (0.34875 g/50mL) + Isopropyl alcohol (0.75 g/50mL) + Kojic acid (2.5 g/50mL) + Lactic acid (5 g/50mL) + Phenoxyethanol (0.225 g/50mL) + Propylene glycol (0.5 g/50mL) + Salicylic acid (1 g/50mL) + Water (7.333 mL/50mL) Liquid Topical ANUBIS COSMETICS SL 2022-11-04 Not applicable US Obagi Ascorbyl glucoside (2.4 mg/30mL) + Ascorbic acid (3.6 mg/30mL) Liquid Topical YS PLUS CORPORATION 2014-10-01 2015-12-31 US Obagi Ascorbyl glucoside (1.5 g/30g) + Ascorbic acid (3 g/30g) Liquid Topical YS PLUS CORPORATION 2014-10-01 2015-12-31 US Obagi Ascorbyl glucoside (2.4 g/30g) + Ascorbic acid (3.6 g/30g) Liquid Topical YS PLUS CORPORATION 2014-10-01 2015-12-31 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Obagi Ascorbyl glucoside (2.4 mg/30mL) + Ascorbic acid (3.6 mg/30mL) Liquid Topical YS PLUS CORPORATION 2014-10-01 2015-12-31 US Obagi Ascorbyl glucoside (1.5 g/30g) + Ascorbic acid (3 g/30g) Liquid Topical YS PLUS CORPORATION 2014-10-01 2015-12-31 US Obagi Ascorbyl glucoside (2.4 g/30g) + Ascorbic acid (3.6 g/30g) Liquid Topical YS PLUS CORPORATION 2014-10-01 2015-12-31 US Sandawha Vitamin C Brightening Essence Ascorbyl glucoside (2 g/100mL) Liquid Topical SKINCURE INC 2020-11-23 Not applicable US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as fatty acyl glycosides of mono- and disaccharides. These are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol or of a phosphorylated alcohol (phosphoprenols), a hydroxy fatty acid or to one carboxyl group of a fatty acid (ester linkage) or to an amino alcohol.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Fatty Acyls
- Sub Class
- Fatty acyl glycosides
- Direct Parent
- Fatty acyl glycosides of mono- and disaccharides
- Alternative Parents
- Hexoses / O-glycosyl compounds / Oxanes / Butenolides / Vinylogous acids / Enoate esters / Lactones / Secondary alcohols / Polyols / Oxacyclic compounds show 6 more
- Substituents
- 2-furanone / Acetal / Alcohol / Aliphatic heteromonocyclic compound / Alpha,beta-unsaturated carboxylic ester / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Dihydrofuran / Enoate ester show 18 more
- Molecular Framework
- Aliphatic heteromonocyclic compounds
- External Descriptors
- glycoside (CHEBI:81685)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2V52R0NHXW
- CAS number
- 129499-78-1
- InChI Key
- MLSJBGYKDYSOAE-DCWMUDTNSA-N
- InChI
- InChI=1S/C12H18O11/c13-1-3(15)9-8(19)10(11(20)22-9)23-12-7(18)6(17)5(16)4(2-14)21-12/h3-7,9,12-19H,1-2H2/t3-,4+,5+,6-,7+,9+,12+/m0/s1
- IUPAC Name
- (5R)-5-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-3-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,5-dihydrofuran-2-one
- SMILES
- OC[C@H](O)[C@H]1OC(=O)C(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)=C1O
References
- General References
- Not Available
- External Links
- KEGG Compound
- C18339
- ChemSpider
- 18678797
- 1306933
- ChEBI
- 81685
- ChEMBL
- CHEMBL2011961
- ZINC
- ZINC000100022089
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Topical Liquid Topical 2 g/100mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 168.0 mg/mL ALOGPS logP -2.7 ALOGPS logP -4.2 Chemaxon logS -0.3 ALOGPS pKa (Strongest Acidic) 4.14 Chemaxon pKa (Strongest Basic) -3 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 10 Chemaxon Hydrogen Donor Count 7 Chemaxon Polar Surface Area 186.37 Å2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 69.45 m3·mol-1 Chemaxon Polarizability 29.81 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Drug created at December 03, 2015 16:52 / Updated at June 12, 2020 16:53